BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 34 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quarry LP | 455,000 | $4,845,750 | 1.58% |
| Spartan Fund Management Inc. | 270,578 | $3,414,730 | 0.83% |
| First Trust Capital Management L.P. | 1,106,378 | $11,782,926 | 0.70% |
| Radcliffe Capital Management, L.P. | 718,747 | $7,654,656 | 0.65% |
| Westchester Capital Management, LLC | 1,390,000 | $14,803,501 | 0.46% |
| METEORA CAPITAL, LLC | 235,223 | $2,505,125 | 0.46% |
| BERKLEY W R CORP | 597,631 | $6,364,770 | 0.38% |
| MIZUHO SECURITIES USA LLC | 1,014,334 | $10,731,654 | 0.36% |
| Exos TFP Holdings LLC | 60,000 | $639,000 | 0.32% |
| AQR Arbitrage LLC | 482,993 | $5,143,875 | 0.22% |
| GLAZER CAPITAL, LLC | 308,120 | $3,281 | 0.22% |
| FIR TREE CAPITAL MANAGEMENT LP | 216,565 | $2,306,417 | 0.22% |
| PERISCOPE CAPITAL INC. | 250,000 | $2,662,500 | 0.21% |
| KIM, LLC | 200,000 | $2,130,000 | 0.18% |
| UBS OCONNOR LLC | 453,158 | $4,826,133 | 0.15% |
| LINDEN ADVISORS LP | 1,000,000 | $10,650,000 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 150,000 | $1,597,500 | 0.10% |
| Centiva Capital, LP | 426,937 | $4,546,879 | 0.10% |
| Atlas Merchant Capital LLC | 50,000 | $532,500 | 0.10% |
| Saba Capital Management, L.P. | 323,142 | $3,441,462 | 0.09% |
This page lists BIOPLUS ACQUISITION CORP's shareholders in Q2 2023. To view BIOPLUS ACQUISITION CORP's shareholder history, click here.